comparemela.com

Latest Breaking News On - Innocare pharma - Page 1 : comparemela.com

InnoCare Pharma concludes subject enrolment Phase II psoriasis trial

The trial aims to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of ICP-488 in adult patients.

InnoCare Pharma Limited (OTCMKTS:INCPF) Sees Significant Growth in Short Interest

InnoCare Pharma Limited (OTCMKTS:INCPF – Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,943,400 shares, a growth of 8.4% from the March 31st total of 2,714,400 shares. Based on an average trading volume of 0 shares, […]

InnoCare Pharma Limited (OTCMKTS:INCPF) Sees Significant Increase in Short Interest

InnoCare Pharma Limited (OTCMKTS:INCPF – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 2,943,400 shares, an increase of 8.4% from the March 31st total of 2,714,400 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio […]

AriBio Sells China Rights To Alzheimer s Candidate In $770M Deal

AriBio Sells China Rights To Alzheimer s Candidate In $770M Deal
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib

InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.